Frank C. Eisenschenk

Array ( [id] => 3655355 [patent_doc_number] => 05622836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Monoclonal antibodies which recognize malignant cells from bladder carcinomas' [patent_app_type] => 1 [patent_app_number] => 8/261009 [patent_app_country] => US [patent_app_date] => 1994-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 30 [patent_no_of_words] => 14883 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622836.pdf [firstpage_image] =>[orig_patent_app_number] => 261009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682789 [patent_doc_number] => 05695757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Methods for treating post-exposure rabies and anti-rabies compositions' [patent_app_type] => 1 [patent_app_number] => 8/255557 [patent_app_country] => US [patent_app_date] => 1994-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4157 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695757.pdf [firstpage_image] =>[orig_patent_app_number] => 255557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662761 [patent_doc_number] => 05599539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Therapy for clostridial botulinum toxin' [patent_app_type] => 1 [patent_app_number] => 8/255009 [patent_app_country] => US [patent_app_date] => 1994-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10944 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599539.pdf [firstpage_image] =>[orig_patent_app_number] => 255009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993347 [patent_doc_number] => 05858358 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Methods for selectively stimulating proliferation of T cells' [patent_app_type] => 1 [patent_app_number] => 8/253751 [patent_app_country] => US [patent_app_date] => 1994-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 48 [patent_no_of_words] => 19064 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858358.pdf [firstpage_image] =>[orig_patent_app_number] => 253751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689351 [patent_doc_number] => 05679345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Method for preventing complement-dependent rejection of organ or tissue transplants' [patent_app_type] => 1 [patent_app_number] => 8/253279 [patent_app_country] => US [patent_app_date] => 1994-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12982 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679345.pdf [firstpage_image] =>[orig_patent_app_number] => 253279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3845081 [patent_doc_number] => 05708145 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Immunglobulins reactive with protegrins' [patent_app_type] => 1 [patent_app_number] => 8/243879 [patent_app_country] => US [patent_app_date] => 1994-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 13014 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708145.pdf [firstpage_image] =>[orig_patent_app_number] => 243879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737979 [patent_doc_number] => 05698680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Antibodies specific for lipopolysaccharide binding protein' [patent_app_type] => 1 [patent_app_number] => 8/240328 [patent_app_country] => US [patent_app_date] => 1994-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 22579 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698680.pdf [firstpage_image] =>[orig_patent_app_number] => 240328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3969059 [patent_doc_number] => 05886152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Humanized B-B10' [patent_app_type] => 1 [patent_app_number] => 8/232081 [patent_app_country] => US [patent_app_date] => 1994-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10792 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886152.pdf [firstpage_image] =>[orig_patent_app_number] => 232081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888593 [patent_doc_number] => 05714585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Antibodies that are immunoreactive with interleukin-7' [patent_app_type] => 1 [patent_app_number] => 8/231205 [patent_app_country] => US [patent_app_date] => 1994-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 17703 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714585.pdf [firstpage_image] =>[orig_patent_app_number] => 231205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604229 [patent_doc_number] => 05589174 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Anti-human influenza virus antibody' [patent_app_type] => 1 [patent_app_number] => 8/229781 [patent_app_country] => US [patent_app_date] => 1994-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28457 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589174.pdf [firstpage_image] =>[orig_patent_app_number] => 229781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775617 [patent_doc_number] => 05808032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Anti-HBS antibody genes and expression plasmids therefor' [patent_app_type] => 1 [patent_app_number] => 8/157101 [patent_app_country] => US [patent_app_date] => 1994-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6800 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808032.pdf [firstpage_image] =>[orig_patent_app_number] => 157101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647322 [patent_doc_number] => 05639656 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Antibodies reactive with biological markers of benign prostate hyperplasia' [patent_app_type] => 1 [patent_app_number] => 8/221821 [patent_app_country] => US [patent_app_date] => 1994-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26429 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639656.pdf [firstpage_image] =>[orig_patent_app_number] => 221821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730477 [patent_doc_number] => 05665595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Immunoglobulins against insect tissue' [patent_app_type] => 1 [patent_app_number] => 8/216119 [patent_app_country] => US [patent_app_date] => 1994-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9861 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665595.pdf [firstpage_image] =>[orig_patent_app_number] => 216119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663928 [patent_doc_number] => 05597710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Humanized monoclonal antibodies against human interleukin-4' [patent_app_type] => 1 [patent_app_number] => 8/208886 [patent_app_country] => US [patent_app_date] => 1994-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19341 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597710.pdf [firstpage_image] =>[orig_patent_app_number] => 208886 [rel_patent_id] =>[rel_patent_doc_number] =>)